Red Queen Bio

Developer of AI-enabled biodefense countermeasures to address emerging biological threats. It engineers scalable processes for mapping AI-enabled biothreats and pre-building medical countermeasures. The company's countermeasure design pipeline is built upon models, lab automation, and reinforcement learning. This is combined with on-demand biologics manufacturing to provide a technological foundation for defensive co-scaling. It engages with policymakers on incentives for the private sector. The company is committed to open collaboration with AI labs, biopharma, and governments.